Last $0.13 USD
Change Today 0.00 / 0.00%
Volume 600.0
ABMC On Other Exchanges
Symbol
Exchange
OTC US
As of 11:09 AM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

american bio medica corp (ABMC) Snapshot

Open
$0.13
Previous Close
$0.13
Day High
$0.13
Day Low
$0.13
52 Week High
11/5/14 - $0.90
52 Week Low
12/22/14 - $0.10
Market Cap
3.1M
Average Volume 10 Days
856.0
EPS TTM
$0.0004
Shares Outstanding
23.6M
EX-Date
--
P/E TM
335.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for AMERICAN BIO MEDICA CORP (ABMC)

Related News

No related news articles were found.

american bio medica corp (ABMC) Related Businessweek News

No Related Businessweek News Found

american bio medica corp (ABMC) Details

American Bio Medica Corporation develops, manufactures, and sells immunoassay tests for the immediate point of collection testing (POCT) for drugs of abuse (DOA) in urine and oral fluids. It provides urine-based POCT products that comprise Rapid Drug Screen to detect the presence or absence of 2 to 10 DOA; Rapid ONE for testing the presence or absence of a single DOA; RDS InCup, which detects the presence or absence of 2 to 12 DOA; Rapid TOX that detects the presence or absence of 2 to 10 DOA; and Rapid TOX Cup II for detecting the presence or absence of 2 to 14 DOA. The company’s urine-based POCT products test various drugs, including amphetamines, barbiturates, benzodiazepines, buprenorphine, cocaine, MDMA, methadone, methamphetamines, opiates, oxycodone, phencyclidine, propoxyphene (PCP), marijuana (THC), and tricyclic antidepressants. It also offers oral fluid based POCT products comprising OralStat to detect DOA; and Rapid Status II that enhances drug recovery and provides a transport container for confirmation of positive test results. The company’s oral fluid based POCT products test amphetamines, barbiturates, benzodiazepines, cocaine, MDMA, methadone, methamphetamines, opiates, PCP, propoxyphene, and THC drugs. In addition, it distributes Rapid Reader, a compact portable unit that uses a camera to capture a picture of the results obtained when using an ABMC POCT product; and POCT products to detect the presence or absence of adulterants and alcohol. Further, the company offers bulk strip contract manufacturing services to various non-affiliated POCT diagnostic companies. It serves workplace, government, clinical, rehabilitation, and education markets directly, as well as through distributors in the United States and internationally. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was founded in 1986 and is based in Kinderhook, New York.

72 Employees
Last Reported Date: 03/31/14
Founded in 1986

american bio medica corp (ABMC) Top Compensated Officers

Chief Executive Officer and Principal Account...
Total Annual Compensation: $105.9K
Compensation as of Fiscal Year 2013.

american bio medica corp (ABMC) Key Developments

American Bio Medica Corporation Announces Board Changes

On December 11, 2014, Edmund M. Jaskiewicz informed the Board of Directors of American Bio Medica Corporation of his decision to step down from his position of Director and Chairman of the Board of Directors. On December 19, 2014, the company's Board of Directors received written confirmation of this decision in a letter from Mr. Jaskiewicz dated December 17, 2014. On December 22, 2014, upon recommendation of the company's Nominating Committee of the Board of Directors, the Board of Directors appointed Diane J. Generous to fill the board seat vacancy created by Mr. Jaskiewicz's resignation. On December 22, 2014, upon recommendation of the company's Nominating Committee of the Board of Directors, the Board of Directors appointed Richard P. Koskey to the position of Chairman of the Board of Directors. Mr. Koskey has been a director of the company since 2003 and he currently serves as the Chairman of the Audit Committee of the company's Board of Directors and as a member of the Compensation and Nominating Committees.

American Bio Medica Corp. Consolidates its Operation and Closes Two Sites in New Jersey

American Bio Medica Corp. is consolidating its operation and cutting other costs under its strategy to compete with overseas competitors. Among the steps is the closing two of company's three manufacturing sites in Logan Township, New Jersey. Some of the operations will be relocated to the company's headquarters in Kinderhook, New York, about 25 miles south of Albany. The company expects to spend about $80,000 to close and relocate the two New Jersey operations, which are about 25 miles south of Philadelphia, Pennsylvania. The reason for the relocation includes closing two leased Logan Township, New Jersey properties in favor of the Kinderhook, New York buildings and land owned by American Bio Medica Corp., which should play a role in generating at least $80,000 in annual savings.

American Bio Medica Corporation Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

American Bio Medica Corporation announced unaudited earnings results for the third quarter and nine months ended September 30, 2014. Net sales for the third quarter of 2014 were $1,750,000, compared to $2,257,000 in the third quarter of 2013, representing a decrease of $507,000, or 22.5%. The company reported an operating loss of $124,000 in the third quarter of 2014, compared to an operating loss of $286,000 in the third quarter of 2014. Net loss for the third quarter of 2014 was $211,000, or $0.01 per Basic & diluted share, compared to a net loss of $213,000, or $0.01 per Basic & diluted share in the third quarter of 2013. Loss before tax was $211,000 against $216,000 a year ago. For the nine months ended September 30, 2014, net sales were $5,604,000, compared to $6,762,000 for the nine months ended September 30, 2013, representing a decrease of $1,158,000, or 17.1%. Operating loss for the nine months ended September 30, 2014 was $39,000, compared to an operating loss of $860,000 in the nine months ended September 30, 2013. Net loss for the nine months ended September 30, 2014 was $252,000, or $0.01 per Basic & diluted share, compared to a net loss of $933,000, or $0.04 per Basic & diluted share in the nine months ended September 30, 2013. Loss before tax was $251,000 against $935,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABMC:US $0.13 USD 0.00

ABMC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $40.95 USD -0.25
OraSure Technologies Inc $9.84 USD -0.06
View Industry Companies
 

Industry Analysis

ABMC

Industry Average

Valuation ABMC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.4x
Price/Book 2.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMERICAN BIO MEDICA CORP, please visit www.abmc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.